Cancer immunotherapy is showing huge promise as a cancer treatment strategy. This approach aims to utilize the patient’s own immune system to target and kill the cancer cells. One barrier to successful cancer immunotherapy is the tumor microenvironment, which recruits immunosuppressive cells that can inhibit endogenous anti-tumor responses.
